Skip to main content
Caplight Logo









IMADIS Groupe

IMADIS Groupe

Private
LyonHealthcare & Life Scienceshttps://www.imadis-groupe.fr/

Last Round

Series A

Sep 19, 2024

Total Funding Raised

$11.17M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

IMADIS Groupe operates in Healthcare & Life Sciences and is based in Lyon. Its latest recorded funding round was a Series A round in September 2024.

IMADIS Groupe is a healthcare services company that provides 24/7 remote emergency teleradiology interpretation services to hospitals and medical centers.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Medical Imaging, Workflow Automation

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

IMADIS Groupe Comparables

Compare IMADIS Groupe with similar companies based on industry and business-model similarity.

IMADIS Groupe comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MEDIN+
87%
TeleDiag
86%
Raya Diagnostics
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

IMADIS Groupe Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 19, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 117% MoM.

  • Jun 20, 2026

    Monthly visitors increased 44% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

IMADIS Groupe Filings

Explore SEC and related filing metadata, where available.

IMADIS Groupe filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about IMADIS Groupe's valuation, stock price, and market status.

Is IMADIS Groupe a public or private company?

IMADIS Groupe is a private company.

What is the current stock price of IMADIS Groupe?

IMADIS Groupe is a private company, so its shares have no public market price. Caplight tracks IMADIS Groupe's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is IMADIS Groupe worth (valuation)?

Valuation information for IMADIS Groupe is not publicly available.

Can I buy IMADIS Groupe stock?

IMADIS Groupe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was IMADIS Groupe's last funding round?

IMADIS Groupe's most recent funding round was Series A on September 19, 2024.

Who are the main investors in IMADIS Groupe?

Investor information for IMADIS Groupe is not publicly disclosed.

Will IMADIS Groupe IPO soon?

No public IPO plans have been announced for IMADIS Groupe.

How can I track IMADIS Groupe secondary market activity?

Caplight tracks bids, offers, and trades in IMADIS Groupe's shares on secondary markets.

Firmographic Details

HeadquartersLyon
Employee Range208
Year Founded2008
Last FundingSep 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?